Geriatric Medication Safety: How to Protect Elderly Patients from Harmful Drugs

Every year, more than 177,000 older adults in the U.S. are hospitalized because of dangerous drug reactions. Many of these cases aren’t accidents-they’re preventable. As people live longer, more are taking five, six, even ten medications daily. Some of those drugs, once considered safe, are now known to be risky for seniors. The problem isn’t just the number of pills-it’s the wrong pills for the wrong body.

Why Older Bodies Handle Medications Differently

As we age, our bodies change in ways most doctors don’t fully account for. The liver and kidneys don’t filter drugs as quickly. Fat increases, muscle decreases, and water content drops. This means drugs stick around longer, build up in the system, and hit harder. A dose that was fine at 50 can become toxic at 75.

Take benzodiazepines, like diazepam or lorazepam. They’re often prescribed for anxiety or sleep. But in seniors, they double the risk of falls, which can lead to hip fractures-sometimes fatal. The same goes for anticholinergics, found in many over-the-counter sleep aids and bladder medications. These drugs fog the brain, causing confusion, memory loss, and even delirium. Studies show seniors on these meds are 60% more likely to lose their ability to walk independently.

It’s not just about side effects. It’s about how drugs interact. A senior on warfarin for atrial fibrillation who also takes an NSAID like ibuprofen for arthritis has a much higher chance of internal bleeding. Add in an SSRI for depression, and the risk spikes again. These aren’t rare events. They happen every day in homes, clinics, and emergency rooms.

The Beers Criteria: The Gold Standard for Safer Prescribing

In 1991, the American Geriatrics Society created the Beers Criteria-a list of medications that are generally unsafe for older adults. It’s been updated every three years since. The latest version, released in 2023, is more detailed than ever.

The 2023 Beers Criteria flag 139 medications or drug classes as potentially inappropriate. Some are banned outright for most seniors: meperidine (a painkiller), diphenhydramine (Benadryl), and chlorpropamide (an old diabetes drug). Others are risky under certain conditions: NSAIDs like indomethacin for those with kidney issues, or opioids like oxycodone for people with a history of falls.

One major update: aspirin is no longer recommended for primary heart disease prevention in people over 70. Earlier guidelines said 80+, but new data showed bleeding risk outweighs benefit even at 70. Another new addition: tramadol. It’s often seen as a safer opioid, but it can cause dangerously low sodium levels, especially when taken with diuretics or antidepressants.

What makes the Beers Criteria powerful isn’t just the list-it’s how it’s used. Epic, the largest electronic health record system in the U.S., now integrates Beers alerts in 87% of its geriatric installations. When a doctor tries to prescribe a flagged drug to a 78-year-old, the system pops up a warning. But here’s the catch: if the alerts are too loud, doctors ignore them. One ER doctor reported a 65% override rate because the system flagged warfarin-even when it was clearly needed.

The Missing Piece: What to Use Instead

Knowing what not to prescribe is only half the battle. The real challenge? What to prescribe instead.

In July 2025, the American Geriatrics Society released the AGS Beers Criteria® Alternatives List-a groundbreaking companion tool. For the first time, clinicians get evidence-based options to replace dangerous drugs.

For insomnia, instead of benzodiazepines, try cognitive behavioral therapy for insomnia (CBT-I). It’s just as effective, lasts longer, and carries zero fall risk. For chronic pain, physical therapy and tai chi outperform NSAIDs without the stomach or kidney damage. For agitation in dementia, structured routines and music therapy reduce symptoms better than antipsychotics, which increase stroke risk.

The Alternatives List includes 47 options across 12 categories. Nearly 40% are non-drug treatments. That’s huge. A 2023 survey found 68% of primary care doctors felt stuck when trying to stop a harmful med-they just didn’t know what to put in its place. The Alternatives List fixes that.

At the Mayo Clinic’s emergency department, pharmacists started using this list during discharge planning. Within six months, they cut potentially inappropriate prescriptions by 38%. One patient, an 82-year-old woman on three sedatives and an anticholinergic for sleep and incontinence, was switched to scheduled toileting, a bedtime routine, and melatonin. Her confusion cleared in two weeks. She stopped falling. She went home.

How Emergency Rooms Are Leading the Change

Emergency departments are ground zero for geriatric medication errors. Seniors arrive after a fall, confusion, or overdose-and often leave with the same dangerous prescriptions.

The Geriatric Emergency Medication Safety Recommendations (GEMS-Rx), developed in March 2024, targets exactly this. It’s a focused toolkit for EDs, listing eight high-risk drug classes to avoid at discharge: antipsychotics, benzodiazepines, anticholinergics, NSAIDs, opioids, diphenhydramine, sulfonylureas, and gabapentinoids.

EDs using GEMS-Rx saw a 29% drop in high-risk prescriptions. Rural clinics, where specialist support is scarce, found the simplified decision trees especially helpful. But implementation isn’t easy. One hospital spent 12 weeks training staff, redesigning workflows, and adding pharmacist roles. They needed 0.5 full-time pharmacist per 20,000 annual visits to make it stick.

CMS, the federal health program, noticed. In 2025, they made medication safety a core requirement for emergency departments under Measure 238. Now, hospitals must track how often seniors are prescribed two drugs from the same high-risk class-like two different benzodiazepines or two NSAIDs. Non-compliant hospitals face reimbursement cuts.

The Human Side: When Guidelines Clash With Real Life

Not every senior fits the textbook. That’s where things get messy.

Dr. Joanne Schnur pointed out in JAMA Internal Medicine that rigidly applying Beers Criteria can hurt. A frail 88-year-old with advanced cancer and severe pain might need an opioid-even if it’s on the list. Denying relief because of a guideline isn’t safety-it’s neglect.

Another case: a 68-year-old man with high cholesterol, diabetes, and a strong family history of heart attack. He’s under 70, so the new aspirin rule doesn’t apply. But his doctor, afraid of breaking the guideline, holds off. He has a heart attack six months later. The guideline helped many-but failed him.

That’s why the best programs don’t treat Beers Criteria as a rulebook. They treat it as a conversation starter. The goal isn’t to eliminate all risky drugs-it’s to make sure every prescription is intentional. Does this drug still serve a purpose? Are there safer alternatives? What does the patient value most-living longer, or feeling better now?

At the University of Alabama at Birmingham, pharmacists sit with patients during discharge. They ask: "What’s your biggest worry right now?" Sometimes it’s pain. Sometimes it’s staying out of the hospital. Sometimes it’s being able to play with grandkids. That answer guides the choices.

What Works in Real Hospitals

Successful programs share three things: teamwork, training, and time.

• Teamwork: Geriatric medication safety isn’t a doctor’s job alone. It needs pharmacists, nurses, social workers, and sometimes even family caregivers. The JAMA meta-analysis showed multidisciplinary teams reduced inappropriate prescriptions by 37%, far more than computer alerts alone.
• Training: The AGS recommends at least 8 hours of focused education. Pharmacists need board certification in geriatric pharmacy (BCGP). Only 1,247 hold it nationwide. That’s not enough.
• Time: A 10-minute visit won’t fix polypharmacy. It takes 20-30 minutes to review a senior’s full med list, check for interactions, and explain changes. Most clinics don’t schedule that time. They should.

One rural clinic in Iowa added a 15-minute "medication check-up" to every annual visit for patients over 65. Within a year, they cut high-risk prescriptions by 41%. No fancy tech. Just a nurse, a checklist, and a willingness to ask, "Why are you still taking this?"

What’s Next: AI, Regulations, and the Road Ahead

The future of geriatric safety is digital-but not in the way you think.

In 2026, CMS will expand Measure 238 to track deprescribing, not just risky prescriptions. Hospitals will be rewarded for stopping harmful drugs, not just avoiding them. Ten new medications are being added to the high-risk list, including gabapentin and proton pump inhibitors.

The AGS is also developing AI-driven standards for Beers Criteria alerts, expected in early 2026. Instead of popping up for every senior, the system will learn context: Is the patient in hospice? Do they have kidney failure? Are they on a blood thinner? Only then will the alert trigger.

But technology alone won’t fix this. The real barrier is workforce. Only 3.2% of pharmacists specialize in geriatrics, even though seniors take 16% of all prescriptions. Without more trained professionals, guidelines stay on paper.

The solution? Integrate geriatric medication safety into every level of care-from ER to home. The Johns Hopkins Hartford Foundation calls it "seamless medication management." It means the same pharmacist who reviews meds in the ER also calls the patient’s primary doctor a week later. It means family members get clear instructions. It means stopping a drug isn’t the end-it’s the start of a better plan.

By 2030, medication-related problems will cost the U.S. over $500 billion a year. But we already have the tools to cut that number in half. It’s not about new drugs. It’s about using the ones we have more wisely.